Teosyal Fillers: What the Name Covers and What to Ask

Your clinician’s proposal says “Teosyal”, a friend says her result looks subtle, and online you see the same brand used for lips, cheeks and the under-eye area. Is this one universal filler, or several different products? Teosyal is a family of hyaluronic acid injectable products from Swiss company Teoxane, not a single injection. To make an informed choice, you need the exact product version, planned area, applicable instructions and a qualified clinician. A reputable brand does not guarantee a natural-looking result.

The range includes TEOSYAL PureSense and TEOSYAL RHA, with distinct properties and purposes. Some formulations contain lidocaine, a local anaesthetic that helps reduce injection pain. These are medical devices for professional use, not everyday cosmetic serums. A name on an overseas website does not prove that a particular version is registered, supplied or used in Armenia.

What is being injected, and why is “Teosyal” not enough information?

Hyaluronic acid occurs naturally in body tissues; in a filler, it is made into a specially formulated gel. Different gels respond differently to movement and pressure, hold volume and spread through tissue in different ways. A clinician should select properties suited to the indication and injection depth, not simply the “strongest” product. Marketing may call this adaptation to facial movement, but a material’s properties are not the same as the clinical outcome on your face.

RHA stands for resilient hyaluronic acid, a formulation family designed with moving facial areas in mind. That is a stated design characteristic, not a guarantee that the gel can never be felt, move from the original site or affect facial expressions. Suitability depends on tissue thickness, treatment goal, previous procedures and the product’s precise regulatory status.

Example product name	What the manufacturer’s materials describe	What to ask separately
PureSense Redensity 1	Marketed for skin-quality changes and fine superficial concerns; it is not equivalent to a volumising filler	What precise goal, area and permissible method are listed in the local instructions?
PureSense Redensity 2	Described in information for certain markets as intended for correcting the hollow under the eyes	Is my anatomy suitable? Are puffiness, bags or product-specific limitations a concern?
RHA 1 / RHA 2 / RHA 3	Typical uses differ, from fine lines to more prominent folds; indications vary by country	Which numbered product, which anaesthetic ingredient and what injection depth?
RHA 4	European instructions include deep folds and volume restoration in selected regions, including temples	Is a European indication being wrongly applied to a US version or another treatment area?
PureSense Kiss / Ultra Deep	These are not alternative names for RHA; they are distinct products for particular contour and volume goals	Why this precise product rather than another within the family?

This table explains naming; it is not a guide for choosing a product yourself. The official documentation for the exact product supplied in the country of treatment still governs. Do not substitute any product labelled “Teosyal for eyes” for Redensity 2, or any “Teosyal for temples” for RHA 4. A small mismatch under the eye may appear as persistent puffiness, while the temple has especially complex vascular anatomy.

What do product instructions establish, and what does research establish?

Teoxane publishes separate instructions for use (IFUs) for particular products, including European versions posted in 2024. The European TEOSYAL RHA 4 IFU, for example, includes deep wrinkles and restoration of facial volume, including the temples, but specifically says not to inject that version into the lips or the periorbital region. Other products from the same company may have different indications. The practical lesson is to ask for the complete name and the actual document, not just a logo.

Regulatory authorisation varies by country. The US FDA originally approved certain RHA 2, 3 and 4 products for specific uses, including moderate-to-severe dynamic facial folds in adults aged 22 and over. This is not FDA approval of every product in the European Teosyal range or every location listed in a European IFU. Further US labelling supplements also exist; check the exact version and current official record before treatment. US clearance or approval does not establish whether a product is available in Yerevan.

Clinical trials can provide evidence for specific products and indications, but the source of study funding also matters. One randomised study of RHA Redensity investigated dynamic lines around the mouth and found a benefit over no treatment on a predefined assessment scale. The study was funded by Teoxane and is not independent of the manufacturer. That finding does not prove that every Teosyal product is superior to another brand in lips, temples or under the eyes. Trials with differing methods, rating scales and follow-up periods cannot guarantee how long your personal result will last.

How much change can you expect, and will other people notice?

When the aim is to add volume to a defined hollow, change may be visible soon after injection, but that early appearance combines the gel with the tissue reaction. Swelling and bruising can temporarily make the face look fuller or less symmetrical than it will after settling. Smoothing fine lines is a different objective and does not amount to an overall facelift. A filler cannot remove excess skin or repair impaired muscle function.

Natural-looking results depend on facial assessment, how much is injected, where and how it is placed—not the label alone. Ask: “What is the smallest meaningful change for my goal, and at what point could my usual facial proportions be altered?” If preserving natural expression matters to you, discuss photographs in movement and the view from different angles. There is no reliable equation of “product number + millilitres = guaranteed face.”

Hyaluronic acid filler effects are generally temporary, but the duration varies considerably. Treatment area, gel properties, placement depth and tissue characteristics all play a role. A manufacturer may give an estimated duration for one formula; it is not the exact date the material disappears in every person. Sometimes no further session is required, sometimes a touch-up is discussed. Let the actual examination guide this rather than a subscription or marketing promise.

What happens on the day of treatment?

Before injection the clinician should ask about illnesses, allergies, medicines, past fillers and procedures, examine the skin and discuss the outcome. Mention reactions to local anaesthetics, any history of severe allergies, herpes near the intended area and previous interventions. Contraindications differ by Teosyal version. For example, the European RHA 4 IFU contraindicates use during pregnancy or breastfeeding, with active inflammation or infection at the injection site, autoimmune disease, severe allergy or hypersensitivity to ingredients. Because this version contains lidocaine, it also lists restrictions involving certain heart and liver conditions, heart medicines, epilepsy and porphyria. These are restrictions for that specific version, not automatically for every Teosyal formulation. The decision should be based on an examination and that version’s documentation.

During treatment you may feel a needle prick, pressure, burning or discomfort. Lidocaine in some formulas helps, but does not abolish sensation. Further pain relief depends on the area and clinician’s judgement. The technique, quantity and need for a follow-up visit must be explained for your own case; none can be safely prescribed from a photograph or search query.

Afterwards, small puncture marks, redness, firmness, tenderness, bruising or swelling may occur. The FDA notes that common effects often settle over days or weeks, but delayed nodules or inflammation are possible. Being able to go back to work the same day does not mean you will have no visible marks at a meeting or photo shoot. Before an important event, allow generous time and clarify instructions about makeup, exercise, facial massage, heat and other procedures. A generic social media aftercare sheet is not a substitute for your own clinician’s advice.

The risks and emergency warning signs that matter most

Injectable fillers have risks irrespective of their maker: infection, nodules, unevenness or displacement of material, allergic reactions, inflammation and an unsatisfactory contour. The gravest complication is material entering a blood vessel or obstructing blood flow. The FDA warns this can cause skin necrosis, impaired sight, blindness or stroke. These are uncommon but potentially irreversible harms; calling a gel “soft”, “elastic” or “hyaluronic” does not rule them out.

Seek emergency medical help immediately for sudden visual changes, unusually severe pain during or after injection, pale or mottled grey-blue skin, an unusual intense headache, weakness or facial drooping, or difficulty speaking. Do not wait for a cold compress to help or the receptionist to reply. Increasing redness, fever, a painful lump or persistent swelling calls for prompt medical contact; urgency depends on the symptoms.

In some circumstances hyaluronic acid gels can be reduced with hyaluronidase, but this is another medical procedure with limitations and risks. Dissolving material cannot undo damage to vessels or eyesight that has already happened. So ask whether an emergency plan and the necessary resources are in place, rather than assuming dissolution is guaranteed.

Who should postpone treatment or consider another approach?

Consider postponing if there is inflammation or infection at the site, an unexplained health concern, uncertain expectations or too little time for possible visible marks. Pregnancy and breastfeeding require particular caution: individual versions may be explicitly contraindicated, and treatment is rarely medically necessary. If you take anticoagulants or other important medicines, never stop them on your own; tell the clinician so the risks and next steps can be assessed.

If your main concern is significant tissue sagging, excess skin, puffy under-eye bags or an altered eyelid position, extra volume might not help and could make swelling more obvious. Sometimes a relevant specialist should assess the problem; in other cases skin care, no treatment or a different aesthetic method may make more sense. Compare the problem you want to address, not just brand names.

Teosyal, Juvederm and Stylage: what matters more than “which brand is best?”

Different brands offer different hyaluronic acid gels, and each brand has several formulations. Comparing “Teosyal versus Juvederm” without naming the product, area or objective is as vague as comparing every cream from one company with every cream from another. Check the exact IFU, independent evidence for your goal, the material’s properties, the clinician’s experience in that anatomical region and how an unwanted result would be managed. Other injectable categories may differ substantially in reversibility and should not be treated as interchangeable.

Reviews and images tell only part of the story. Starting anatomy, lighting, facial expression, timing after injection and other procedures may all vary. Ask for consistent photographic angles and the precise products used. Manufacturer promotional photographs without case details are insufficient for informed consent. A quality mark on a package is not a personal outcome forecast.

Six questions to ask before consenting

“What is the full trade name, batch, expiry date and planned volume? May I see the sealed packaging and receive a record of what was injected?”
“For what goal and depth is this version indicated in the applicable local IFU? If the use is off-label, why, and what extra uncertainties does that introduce?”
“How does the expected result compare with doing nothing or choosing another approach?”
“Which contraindications apply to this exact product given my allergies, conditions, medicines and past injections?”
“What is the emergency plan for a vascular complication, and how will I get help after leaving?”
“What is covered by the cost: product, consultation, follow-up or correction? What would I owe if I decline a later stage?”

Exact local pricing and availability of any particular version in Armenia cannot be assumed without independent verification. If the clinician cannot name the formula, pressures you to pay quickly or promises “absolute safety”, postponing is reasonable. Making a good decision starts with knowing exactly what is proposed and why, not simply recognising the brand.

Frequently asked questions

Is Teosyal in a salon serum the same as injectable Teosyal?: No. Similar names in skin-care marketing do not mean identical ingredients, sterility, method of use or medical status. Check the complete name and product category.
Can I bring the empty packaging from my last procedure?: Yes. Bring the box, batch label or injection record if you have them. Even this cannot replace an examination, but it reduces guesswork about what was previously placed.
Must an old filler be removed if it was injected years ago but causes no problems?: Not necessarily. Having older material is not, by itself, a reason to remove it. Before a new procedure the clinician assesses symptoms, tissue condition and any available product details.